Skip to main content
Signal8

MCCOLLUM JAMES W

SEC insider (Form 3/4/5 filer). CIK 0001200889. Director at LENZ Therapeutics, Inc. (LENZ). 3 reported Form 4/5 transactions since Sep 2024; latest on Jun 15, 2026. Located in SOLANA BEACH, CA.

Companies MCCOLLUM JAMES W has filed insider reports for

  • LENZ Therapeutics, Inc. (LENZ): Director
MCCOLLUM JAMES W profile photo

MCCOLLUM JAMES W

CIK: 0001200889

Transaction Breakdown

Open Market Buys (P)1 (33.3%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

LENZ Therapeutics, Inc. logo
LENZ

LENZ Therapeutics, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (3 total)

  • LENZ Therapeutics, Inc. logo
    LENZ

    LENZ Therapeutics, Inc.

    Jun 15, 2026
    Award

    Stock Option (right to buy)

    Direct
    22.1K shares-
  • LENZ Therapeutics, Inc. logo
    LENZ

    LENZ Therapeutics, Inc.

    Nov 7, 2025
    Purchase
    Direct
    10.5K shares at avg. $22.79$239K
  • LENZ Therapeutics, Inc. logo
    LENZ

    LENZ Therapeutics, Inc.

    Jun 11, 2025
    Award

    Stock Option (right to buy)

    Direct
    13.5K shares-

1-3 of 3